Given half a chance, non-scientists can also make discoveries that move medicine forward.
Peter L. Slavin discusses why funding research is key to America’s future.
Peter L. Slavin and David F. Torchiana on the science and importance of Lyme disease.
In most cases, antibiotics do the trick. But when they don’t, symptoms can be devastating. New research aims to discover why.
Attitudes towards hormone therapy have shifted toward a more nuanced approach.
Where do scientific prizes fit in the research funding landscape?
“Smart bubble wrap” could help lead to better prosthetics.
It’s disappointing when seemingly groundbreaking studied can’t be repeated. But it’s happening a lot.
Peter L. Slavin and David F. Torchiana on the value of reproducing research.
Sharply pared budgets could kill the Framingham Heart Study—after 50 years of astonishing research breakthroughs.
No Articles Found.